Mutations in the DNA polymerase and thymidine kinase genes of herpes simplex virus clinical isolates resistant to antiherpetic drugs

Molecular Biology

Volumn 44, Issue 3, 2010, Pages 431-438

  Korovina, A N ^a   Gus'kova, A A ^b   Skoblov, M Yu ^b   Andronova, V L ^c   Galegov, G A ^c   Kochetkov, S N ^a   Kukhanova, M K ^a   Skoblov, Yu S ^d  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^c D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

DNA polymerase; Drug resistance; Herpes simplex virus; Primary structure; Thymidine kinase

Indexed keywords

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 77954168538     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893310030118     Document Type: Article

References (24)

1. Stranska R., van Loon A. M., Polman M., Beersma M. F., Bredius R. G., Lankester A. C., Meijer E., Schuurman R. 2004. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients. Antivir. Ther. 9, 565-575.
2. Andrei G., Fiten R, Froeyen M., de Clercq E., Opdenakker G., Snoeck R. 2007. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions. Antivir. Ther. 12, 719-732.
3. Field HJ., Darby G. K. 1980. Strategies of drag resistance in herpes simplex. Nature. 286, 842.
4. Gilbert C, Bestman-Smith J., Boivin G. 2002. Resistance of herpesviruses to antiviral drugs: Clinical impacts and molecular mechanisms. Drug Resist. Updat. 5, 88-114.
5. Frobert E., Cortay J. C., Ooka T., Najioullah F., Thouvenot D., Lina B., Morfin F. 2008. Genotypic detection of acyclovir-resistant HSV-1: Characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral. Res. 79, 28-36.
6. Coen D. M. 1991. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy. Antiviral. Res. 15, 287-300.
7. Guskova A. A., Zagurny A. V., Skoblov M. Y., Baranova A. V., Andronova V. L., Yankovsky N. K., Galegov G. A., Skoblov Y. S. 2005. Molecular genetic analysis of thymidine kinase of the herpes simplex virus type 1. Mol. Biol. 39, 137-140.
8. L'vov N. D., Andronova V. L., Leont'eva N. A., Galegov G. A. 1999. Isolation of acyclovir-resistant herpes simplex virus strains from clinical material. Vopr. Virusol. 44, 247-249.
9. De Clercq E., Descamps J., Verhelst G., Walker R. T., Jones A. S., Torrence P. F, Shugar D. 1980. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J. Infect. Dis. 141, 563-574.
10. Thompson J. D., Higgins D. G., Gibson T. J. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weight-ing, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680.
11. Brodsky L. I., Drachev A. L., Leontovich A. M., Feranchuk S. I. 1993. A novel method of multiple alignment of biopolymer sequences. Biosystems. 30, 65-79.
12. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. 1990. Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
13. Quinn J. P., Mcgeoch D. J. 1985. DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucleic Acids Res. 13, 8143-8163.
14. Suzutani T., Ishioka K., De Clercq E., Ishibashi K., Kaneko H., Kira T., Hashimoto K., Ogasawara M., Ohtani K., Wakamiya N., Saijo M. 2003. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir. Antimicrob. Agents Chemother. 47, 1707-1713.
15. Suzutani T., Saijo M., Nagamine M., Ogasawara M., Azuma M. 2000. Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection. J. Clin. Microbiol. 38, 1839-1844.
16. Kost R. G., Hill E. L., Tigges M., Straus S. E. 1993. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N. Engl. J. Med. 329, 1777-1782.
17. Skoblov Y. S., Karpenko I. L., Jasko M. V., Kukhanova M. K., Andronova V. L., Galegov G. A., Sidorov G. V, Myasoedov N. F. 2007. Cell metabolism of acyclovir phosphonate derivatives and antiherpesvirus activity of their combinations with alpha2-interferon. Chem. Biol. Drug. Des. 69, 429-434.
18. Liu S., Knafels J. D., Chang J. S., Waszak G. A., Baldwin E. T., Deibel M. R., Jr., Thomsen D. R., Homa F. L., Wells P. A., Tory M. C., Poorman R. A., Gao H., Qiu X., Seddon A. P. 2006. Crystal structure of the herpes simplex virus 1 DNA polymerase. J. Biol. Chem. 281, 18193-18200.
19. Wyles D. L., Patel A., Madinger N., Bessesen M., Krause P. R., Weinberg A. 2005. Development of herpes simplex virus disease in patients who are receiving cidofovir. Clin. Infect. Dis. 41, 676-680.
20. Matthews J. T., Carroll R. D., Stevens J. T., Haffey M. L. 1989. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme. J. Virol. 63, 4913-4918.
21. Matthews J. T., Terry B. J., Field A. K. 1993. The structure and function of the HSV DNA replication proteins: Defining novel antiviral targets. Antiviral Res. 20, 89-114.
22. Hwang Y. T., Smith J. F., Gao L., Hwang C. B. 1998. Mutations in the ExoIII motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities. Virology. 246, 298-305.
23. Kuhn F. J., Knopf C. W. 1996. Herpes simplex virus type 1 DNA polymerase. Mutational analysis of the 3′-5′-exonuclease domain. J. Biol. Chem. 271, 29245-29254.
24. Bestman-Smith J., Boivin G. 2003. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids. J. Virol. 77, 7820-7829.